Opis działalności
ResMed (NYSE:RMD) changes lives with award-winning medical devices and cutting-edge cloud-based software applications that better diagnose, treat and manage sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed is a global leader in connected care, with more than 1 million patients remotely monitored every day.
Zarząd & Rada nadzorcza
| CEO |
| Michael J. Farrell |
| Zarząd |
| Brett Sandercock, Rob Douglas, Lucile Blaise, Bobby Ghoshal, Katrin Pucknat, Justin Leong, Dawn Haake, Vered Keisar, Carlos M. Nunez, Andrew Price, Hemanth Reddy, Michael Rider, Urvashi Tyagi, Amy Wakeham |
| Rada nadzorcza |
| Michael Farrell, Carol J. Burt, Harjit Gill, Jan De Witte, Karen Drexler, Richard Sulpizio, Ronald Taylor, John Hernandez, Desney Tan, Dr. Peter C. Farrell |
Dane firmy
| Nazwa: |
ResMed Inc. |
| Adres: |
9001 Spectrum Center Blvd.,San Diego, California 92123, USA |
| Telefon: |
+1-858-836-5000 |
| Fax: |
+1-858-836-5501 |
| E-mail: |
-
|
| Internet: |
www.resmed.com/ |
| Przemysł: |
Służba zdrowia |
| Sektor: |
Produkty Medyczne |
| Podsektor: |
Zaawansowane Urządzenia Medyczne |
| Koniec roku finansowego: |
30.06 |
| Free float: |
73,75% |
| Data IPO: |
02.06.1995 |
